Table 1 Characteristics of the study subjects
From: Increased circulating obestatin in patients with chronic obstructive pulmonary disease
Control | COPD | |
|---|---|---|
Age, y | 60.41 ± 6.60 | 59.78 ± 8.71 |
Sex, male/female | 13/9 | 20/12 |
Smoking history, pack/year | 12.96 ± 18.19 | 11.40 ± 16.39 |
BMI (kg/m2) | 22.66 ± 2.96 | 18.99 ± 1.00* |
FFM, kg | 24.96 + 4.79 | 24.63 + 5.20* |
Percent body fat, % weight | 55.42 + 7.70 | 49.88 + 8.91* |
Waist circumference (cm) | 76.78 ± 9.64 | 68.13 ± 6.39* |
Hip circumference (cm) | 89.27 ± 7.12 | 84.54 ± 4.34* |
Waist hip ratio | 0.86 ± 0.06 | 0.81 ± 0.05* |
FEV1/FVC, % | 84.41 ± 4.58 | 63.66 ± 6.24* |
FEV1, % predicted | 85.51 + 20.23 | 69.81 + 15.99 |
Total cholesterol (mmol/L) | 4.81 ± 1.16 | 4.68 ± 0.95 |
Triglyceride (mmol/L) | 1.33 ± 0.53 | 1.04 ± 0.40 |
Creatinine (μmol/L) | 88.32 ± 11.41 | 89.63 ± 16.78 |
Uric acid (μmol/L) | 313.41 ± 68.12 | 302.31 ± 60.16 |
Blood urea nitrogen (μmol/L) | 5.59 ± 1.33 | 5.72 ± 1.11 |